Preemptive therapy of cytomegalovirus disease in pediatric transplant recipients.
Green
M
M
Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, PA, USA.
Michaels
M
M
D000956:Antigens, Viral / Q000032:analysis*; D000998:Antiviral Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000032:analysis; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D003657:Decision Making; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D016377:Organ Transplantation / Q000009:adverse effects*; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests
D000956:Antigens, Viral; D000998:Antiviral Agents; D015415:Biomarkers; D007136:Immunoglobulins